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Abstract We investigated the mechanism of development and repair process of glomerular 26 
injury in rat model of habu snake venom (HSV)-induced glomerulonephritis. 27 
Glomerulonephritis was induced in rats by intravenously injecting HSV 3 mg/kg. Renal 28 
tissue was isolated and subjected to immunohistochemical analysis for expression levels of 29 
type IV collagen, heat shock protein 47 (HSP47), transforming growth factor-β (TGF-β) and 30 
matrix metalloproteinase-3 (MMP-3) as well as its transcription factor Ets-1. Expression 31 
levels of HSP47, TGF-β and type IV collagen began to increase in the mesangial area starting 32 
from day 14 and peaking on day 21, followed by gradual decrease. Expression levels of 33 
MMP-3 and Ets-1 started to increase coinciding with peak production of mesangial matrix on 34 
day 21, peaking on day 35, followed by gradual decrease. Expression of MMP-3 and Ets-1 35 
persisted until day 63, while that of HSP47 and type IV collagen returned to baseline level at 36 
this time-point. Time-course changes of extracellular matrix (ECM) accumulation in 37 
glomeruli in HSV-induced glomerulonephritis model were correlated with those of factors 38 
involved in both ECM production and degradation systems. Continued expression of factors 39 
in the degradation system seems particularly important for the repair process. These findings 40 
might lead to new therapies that prevent and repair glomerular injury. 41 




Mesangioproliferative glomerulonephritis is histologically characterized by proliferation of 45 
mesangial cells and accumulation of mesangial matrix. Glomerulonephritis-associated 46 
glomerular injury that progresses irreversibly often results in glomerular sclerosis and poor 47 
prognosis. Although it has been recognized that balance between extracellular matrix (ECM) 48 
production and degradation systems is an important determinant for changes in the ECM 49 
status in nephritic pathology,1,2 the relationship between the two systems has not been 50 
elucidated in detail as yet. 51 
     Heat shock protein 47 (HSP47) is a molecular chaperon indispensable for collagen 52 
production.3 Upregulation of collagen coincides with glomerular sclerosis lesions in a range 53 
of disease settings including IgA nephropathy,4 diabetic nephropathy,5 anti-Thy1 54 
nephropathy,6 chronic kidney rejection,7 radiation nephropathy,8 multiple kidney cysts,9 55 
hypercholesterolemic kidney,10 subtotal nephrectomy model,11,12 and obstructive 56 
nephropathy.13,14 Therefore since upregulation of HSP47 coincides with collagen expression, 57 
HSP47 is thought strongly involved in the process of glomerular sclerosis. 58 
     Matrix metalloproteinases (MMPs), factors in the ECM degradation system, are a 59 
family of zinc-dependent proteinases that have the capacity to break down all components of 60 
the ECM. Currently, there are more than 20 known mammalian MMPs, which can be 61 
subdivided into collagenases (MMP-1, -8, -13, and -18), gelatinases (MMP-2 and -9), 62 
stromelysins (MMP-3, -10 and -11), matrilysins (MMP-7 and -26), membrane-type MMPs 63 
(MMP-14, -15, -16, -17, -24, and -25), and others (MMP-11, -12, -19, -20, -21, -23a, -23b, 64 
-27, and -28).15 Among these, it was reported that MMP-3 is involved in degradation of type 65 
II and IV collagens and was demonstrated highly expressed at sites of collagen 66 
deposition.16,17 67 
     Ets-1 is well known as a transcription factor that directly regulates expression of 68 
MMPs. Indeed, Ets-1 has been reported to induce expression of MMP-3 in rat crescentic 69 
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glomerulonephritis,18 suggesting a close association between Ets-1 and MMP-3. 70 
     Habu snake venom (HSV)-induced reversible mesangioproliferative 71 
glomerulonephritis model is considered useful for elucidating the mechanism for production 72 
and degradation of ECM. Following intravenous injection of HSV, cystic ballooning-type 73 
lesions may be observed in glomeruli within 1 day. Subsequently, marked segmental 74 
proliferative lesions are observable in cystic areas; cellularity decreases and reconstruction of 75 
glomerular tuft gradually occurs over time. Eventually, histological structure of glomeruli 76 
returns almost to normal.19 We used this reversible mesangioproliferative glomerulonephritis 77 
model to investigate time-course changes of expression of ECM production system factors 78 
such as HSP47 and type IV collagen as well as degradation system factors such as Ets-1 and 79 




Male Sprague-Dawley rats weighing 200 g were used. They were housed in standard rodent 84 
cages, at constant ambient temperature (22 ± 1°C) and humidity (85%) with 10 h of light/day, 85 
kept at the Biomedical Research Center of Center for Frontier Life Sciences at Nagasaki 86 
University. The animals had free access to laboratory chow and tap water. 87 
 88 
Experimental design 89 
Based on national regulations and guidelines, all experimental procedures were reviewed and 90 
approved (no. 0605220510) by Institutional Animal Care and Use Committee of Nagasaki 91 
University. 92 
     Rats were intravenously injected with HSV (Trimeresurus flavoviridis; Wako Pure 93 
Chemical Industries, Osaka, Japan) dissolved in saline at a dose of 3 mg/kg body weight 94 
(HSV group, n = 36) whereas control rats were injected with saline alone (S group, n = 4). 95 
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Rats were sacrificed before and on days 7, 14, 21, 28, 35, 49, and 63 after injections (n = 4 96 
each), and renal tissues dissected out carefully. Tissues were fixed with 4% paraformaldehyde 97 
(PFA) immediately after sampling for 24 h, embedded in paraffin, and cut into 3-μm-thick 98 
sections for histological assessment to renal injury. Frozen tissues were also prepared by 99 
mounting in optimal cutting temperature compound (Miles, Elkhart, IN, USA) and rapidly 100 
freezing in dry ice then stored at –80°C until use. Fresh frozen tissues were cut into 101 
3-μm-thick sections using a microtome and placed onto aminopropyltriethoxysaline-coated 102 
slide glasses. 103 
 104 
Histological and immunohistochemical examination 105 
To assess morphological changes in the kidney, paraffin-embedded tissue sections were 106 
stained with periodic acid-Schiff (PAS) reaction. Then, morphological change was compared 107 
between the S group and HSV group. 108 
      The following antibodies were used for immunohistochemical analysis: (1) rabbit 109 
anti-human type IV collagen antibody (10760, Progen Biotechnik, Heidelberg, Germany) 110 
diluted 1/100; (2) mouse anti-mouse HSP47 antibody (Stress-Gen, Victoria, BC, Canada) 111 
diluted 1/100; (3) rabbit anti-mouse TGF-β antibody (sc-146; Santa Cruz Biotechnology, 112 
Santa Cruz, CA, USA) diluted 1/50; (4) rabbit anti-rat MMP-3 antibody (sc-6839, Santa Cruz 113 
Biotechnology) diluted 1/100; (5) rabbit anti-human Ets-1 antibody (sc-350, Santa Cruz 114 
Biotechnology) diluted 1/100. Kidney sections were reacted with methanol containing 0.3% 115 
H2O2 for 20 min at room temperature to block endogenous peroxidase. The peroxidase 116 
anti-peroxidase (PAP) technique was used to assess type IV collagen, MMP-3, and Ets-1 117 
expression in paraffin-embedded or frozen sections. After deparaffinization, sections were 118 
incubated with blocking buffer containing 20% normal swine serum, 5% normal goat serum, 119 
5% fetal calf serum, and 5% bovine serum albumin in phosphate-buffered saline for 30 min. 120 
For Ets-1 antibody, fresh frozen sections fixed in 4% PFA at room temperature were reacted 121 
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for 15 min then incubated with blocking buffer as described above for 30 min. Sections were 122 
then reacted with the primary antibody and diluted in the same blocking buffer. After reacting 123 
with primary antibody at room temperature for 1 h, sections were reacted with horseradish 124 
peroxidase (HRP)-conjugated swine anti-rabbit immunoglobulin antibody (P0399, DAKO, 125 
Japan) diluted 1/50 at room temperature for 30 min and rabbit PAP (Z0113, DAKO) diluted 126 
1/100 at room temperature for 30 min.   127 
     Indirect immunohistochemical analysis was used to detect HSP47 and TGF-β in 128 
paraffin-embedded sections. After deparaffinization, the sections were incubated with 129 
blocking buffer for 30 min as described above. Sections were then reacted with the primary 130 
antibody diluted in the same blocking buffer. After reacting with primary antibody at room 131 
temperature for 1 h, sections were reacted with HRP-conjugated goat anti-mouse antibody 132 
(Millipore, Billerica, MA, USA) diluted 1/100 for HSP47 or HRP-conjugated goat anti-rabbit 133 
antibody (Millipore) diluted 1/100 for TGF-β at room temperature for 1 h. 134 
     For type IV collagen, HSP47, MMP-3, and Ets-1, positive reactions with antibodies 135 
were characterized by color development following reaction with H2O2 and 136 
3,3'-diaminobenzidine tetrahydrochloride (DAB). For TGF-β, HRP-positive sites were 137 
visualized using H2O2 and DAB in the presence of nickel and cobalt ions. Finally, sections 138 
were counterstained with methyl green and mounted. 139 
     Negative control sections were reacted with normal mouse IgG in place of specific 140 
monoclonal antibodies or normal rabbit IgG in place of specific polyclonal antibodies. 141 
 142 
Data processing and statistical analysis 143 
For semiquantitative estimation of PAS-positive area, type IV collagen--, HSP47-, and 144 
MMP-3-positive areas in each glomerulus, we digitized images using image analysis software 145 
(Win Roof Mitanicorp, Chiba, Japan). Images were transformed into a matrix of 2250 × 1800 146 
pixels and viewed at × 400 magnification. For each kidney sample, 20 cross-sections of 147 
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glomeruli were examined sequentially. The total number of glomerular cells, and numbers of 148 
TGF-β- and Ets-1-positive cells were also counted in 20 cross-sections of glomeruli under × 149 
400 magnification in each group. 150 
     Data are expressed as mean ± standard deviation (SD). Differences between groups 151 
were examined for statistical significance by repeated measures ANOVA (Bonferroni/Dunn 152 
test). P-values <0.001 denoted the presence of statistically significant difference. 153 
 154 
Results 155 
Histological changes (PAS staining) 156 
In S group mesangial cell proliferation and matrix increase were not observed throughout the 157 
observation period (data not shown), and the staining pattern remained the same as that of 158 
HSV group on day 0 (Fig. 1A). On the other hand, in HSV group mesangial cell proliferation 159 
and matrix increase were observed on day 21 following HSV injection with a significant 160 
difference from those seen on day 0 (Fig. 1B). Mesangial cell proliferation and matrix 161 
increase were significantly reduced on day 35 (Fig. 1C) compared with on day 21, and the 162 
histological pattern on day 63 was almost the same as that on day 0 (Fig. 1D). Time-course 163 
change of mesangial matrix was semiquantitatively analyzed by imaging system; the results 164 
are displayed in Fig. 1E. 165 
 166 
Expression of type IV collagen 167 
Figure 2 shows immunohistochemical staining of type IV collagen. In S group, slight 168 
deposition of type IV collagen in the mesangial area was observed throughout the observation 169 
period (data not shown), and the staining pattern remained the same as that of HSV group on 170 
day 0 (Fig. 2A). In contrast, in HSV group, upregulation of type IV collagen was observed on 171 
day 21 following HSV injection coinciding with the spread of mesangial area (Fig. 2B). 172 
Upregulation of type IV collagen in mesangial area was significantly reduced on day 35 (Fig. 173 
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2C) compared with day 21, and the expression level on day 63 was the same as that on day 0 174 
(Fig. 2D). Positive area for type IV collagen as semiquantitatively analyzed by imaging 175 
system over time is presented in Fig. 2E. 176 
 177 
Expression of HSP47 178 
In S group little or no HSP47-positive cells in the glomeruli were observed throughout the 179 
observation period, as in HSV group on day 0 (Fig. 3A). However, HSP47-positive cells were 180 
significantly increased in HSV group starting on day 14 and peaking on day 21 following 181 
HSV injection, coinciding with the peak expression of type IV collagen (Fig. 3B). The level 182 
of HSP47-positive cells decreased thereafter till day 63, when almost no positive cells were 183 
detected in glomeruli (Fig. 3C, D). Time-course change of HSP47-positive cell count in 184 
glomeruli is shown in Fig. 3E. 185 
 186 
Expression of TGF-β 187 
TGF-β is widely known to be an important mediator in progressive fibrosis. Previous reports 188 
have demonstrated that TGF-β facilitated mesangial cell proliferation and stimulated ECM 189 
production by mesangial cells. 20 We therefore examined TGF-β expression. Few or no 190 
TGF-β-positive cells were observed in the glomeruli in the S group throughout the 191 
observation period, or in the HSV group on day 0 (Fig. 4A). However, TGF-β-positive cells 192 
increased significantly in the HSV group starting on day 14 and peaking from days 21–35 193 
following HSV injection, coinciding with the peak expression levels of type IV collagen and 194 
HSP47 (Fig. 4B, C). TGF-β-positive cells in glomeruli decreased thereafter until day 63 (Fig. 195 
4D). The time-course of changes in TGF-β-positive cell count in the glomeruli is shown in 196 
Fig. 4E.  197 
 198 
Expression of MMP-3 199 
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In S group little or no expression of MMP-3 in glomeruli was observed throughout the 200 
observation period (data not shown), and the staining pattern was not different from that of 201 
HSV group on day 0 (Fig. 5A). In contrast, in HSV group, MMP-3 expression was increased 202 
on day 21 following HSV injection (Fig. 5B), peaked on day 35 (Fig. 5C), and remained 203 
significantly upregulated thereafter (Fig. 5D). Positive area for MMP-3 was 204 
semiquantitatively analyzed; the time-course change is presented in Fig. 5E. 205 
 206 
Expression of Ets-1 207 
In HSV group Ets-1-positive cells in the glomeruli were significantly increased versus day 0 208 
starting from day 21 (Fig. 6B), peaking on day 35 following HSV injection (Fig. 6C). 209 
Ets-1-positive cells decreased thereafter, but the level on day 63 was still significantly higher 210 
than that on day 0 (Fig. 6A,D). Time-course change of numbers of Ets-1-positive cells in a 211 
single glomerulus is shown in Fig. 6E.  212 
 213 
Discussion 214 
We investigated the time-course change of expression levels of collagen production system 215 
factors and collagen degradation system factors in glomerular cells over the course of 216 
development and repair of glomerular injury using rat model of HSV-induced 217 
glomerulonephritis. Our experiment suggests that histological changes in the glomeruli of 218 
HSV-induced glomerulonephritic rats were attributed to balancing of collagen production and 219 
degradation systems over time, as seen in the initial upregulation of production system factors 220 
followed by upregulation of degradation system factors. 221 
     It was previously reported that, in rat model of HSV-induced glomerulonephritis, 222 
protease derived from intravenously injected HSV promotes mesangiolysis resulting in 223 
mesangial proliferative lesions and subsequent spontaneous remission. 21, 22 In the present 224 
study, mesangiolysis was detected within 24 h of HSV injection followed by peak increase of 225 
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mesangial cells and matrix increases, which spontaneously decreased to baseline levels by 226 
day 63. 227 
     We first investigated factors involved in the production of collagen, an ECM 228 
component, to elucidate the mechanism for the increase of ECM in HSV-induced 229 
glomerulonephritis model. Expression levels of type IV collagen and HSP47, a molecular 230 
chaperon essential for collagen production, started to increase on day 7, peaked on day 21, 231 
and decreased thereafter. This finding suggests that the observed increase in ECM in the 232 
glomeruli in this rat model was attributed to accumulation of type IV collagen via 233 
upregulation of HSP47. That is, extent of glomerular injury was correlated with expression 234 
levels of HSP47 and type IV collagen, indicating strong involvement of HSP47 expression in 235 
the increase of glomerular ECM. It has been reported that administration of antisense and 236 
siRNA against HSP47 reduced collagen accumulation and suppressed fibrosis of peritoneum 237 
and renal interstitium in chlorhexidine-induced peritoneal fibrosis model and unilateral 238 
ureteral ligation model. 23,24 These and our findings suggest that HSP47 could be a potential 239 
therapeutic target in the treatment of diseases that show irreversible increase in glomerular 240 
ECM. Moreover, previous reports have noted a crucial role for TGF-β in ECM production. 241 
TGF-β stimulated expression of types I, III, and IV collagen, laminin, fibronectin, and 242 
heparin sulfate proteoglycans in various assays in cultured human mesangial cells or isolated 243 
perfused kidneys.20 Based on these findings, the time course of TGF-β expression is 244 
consistent with those of HSP47 and type IV collagen. 245 
     We also investigated factors involved in degradation of collagen to elucidate the 246 
mechanism for decrease of ECM. Expression levels of MMP-3 and Ets-1 increased as 247 
mesangial matrix increased starting on day 7 after HSV injection, peaking on day 35, 248 
followed by gradual decrease thereafter but remaining upregulated versus baseline on day 63. 249 
These results suggest that increased expression of Ets-1 and MMP-3 may be involved in the 250 
repair mechanism in HSV-induced glomerulonephritis model. 251 
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     MMP-3 as well as MMP-10 and -11 are classified together as stromelysins, important 252 
for the degradation of ECM components such as collagen type III, IV, and VI, laminin, 253 
aggrecan, and fibronectin. 25, 26 Renal MMP-3 mRNA expression is decreased in rats with 254 
streptozotocin-induced diabetes. 27,28 Similarly, in diabetic nephropathy and IgA nephropathy 255 
expression of MMP-3 mRNA in the glomeruli correlated negatively with the degree of 256 
glomerular injury.16,17 These findings suggest that reduced MMP-3 expression suppresses 257 
ECM degradation resulting in progression of glomerular injury. In the present study, 258 
time-dependent changes of expression of MMP-3, which followed HSP47 and type IV 259 
collagen expression induced by HSV injection, might lead to resolution of ECM in glomeruli. 260 
     Concerning regulation of MMP-3 genes, Ets-1 is known to be a potent transcription 261 
factor for MMP-3. Ets-1 comprises 450 amino acids and contains a DNA-binding ETS 262 
domain, transactivation domain, and Pointed domain. The ETS domain binds to the 263 
ETS-binding motif GGAA/T in the cis-acting element of target genes and cooperates with the 264 
c-Fos/c-Jun complex at AP-1 site to activate expression of certain promoters. This motif has 265 
been found in the promoter region of numerous genes including MMP-1, MMP-3, MMP-9, 266 
u-PA, and TIMP-1. 29,30 In addition, it was reported that Ets-1 blocked intracellular TGF-β 267 
signaling, resulting in suppression of ECM accumulation, and increased the levels of ECM 268 
degradation enzymes MMP-1, -3, and -9 in Thy-1 nephropathy.31 Based on the background 269 
described above, induction of MMPs expression via transcriptional upregulation by Ets-1 is 270 
considered involved in remodeling of glomerular ECM. In our study, the time-course 271 
expression profiles of Ets-1 and MMP-3 are similar, and upregulation of MMP-3 via 272 
induction of Ets-1 is likely part of a mechanism that pushed the balance toward glomerular 273 
ECM degradation leading to reversible change in renal tissue. 274 
There were some limitations to our study. First, the correlation between the 275 
morphological changes and proteinuria or renal function was not verified. However,  276 
previous reports have clarified an association between the levels of proteinuria and type IV 277 
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collagen expression in mesangioproliferative glomerulonephritis models22 , 32 . Nakao et al. 278 
demonstrated a time-course for proteinuria in HSV-induced glomerulonephritis in mice32. 279 
They showed that proteinuria began to increase at day 3 following HSV injection, peaking at 280 
day 7 in parallel with a prominent proliferation of mesangial cells, and an accumulation of 281 
ECM including type IV collagen. The level of proteinuria gradually decreased to baseline 282 
levels by day 42, and the expression level of type IV collagen followed the same course. 283 
Similarly, Masuda et al. revealed that the degree of proteinuria was closely correlated with 284 
the expression of type IV collagen in rat Thy-1/HSV-induced glomerulonephritis22. Based on 285 
these findings, we anticipated that the level of proteinuria was associated with the expression 286 
of type IV collagen in our model, as we observed similar histopathological and 287 
immunohistochemical findings over the course of mesangioproliferative glomerulonephritis. 288 
Second, although we performed western blotting of proteins associated with ECM production 289 
and degradation to confirm the results of immunohistochemical analysis, we were unable to 290 
produce any satisfactory results. However, the semiquantitative immunohistochemical 291 
method we used in the present study has been widely used and reported as a reliable 292 
technique in previous studies33, 34. Third, we were unable to clarify which cells in the 293 
glomeruli expressed the proteins associated with ECM production and degradation, and 294 
which cells in the glomeruli played an important role in the reversible process of 295 
HSV-induced glomerulonephritis. Based on their morphology of positive cells, we speculate 296 
that mesangial cells and podocytes are involved in this process, but further studies are needed 297 
to confirm this hypothesis. 298 
     In conclusion, time-course change of glomerular ECM accumulation during the course 299 
of HSV-induced glomerulonephritis was correlated with that of factors in both ECM 300 
production and degradation systems. Continued expression of factors in ECM degradation 301 
system was considered particularly important for repair process. In future, so as to suppress 302 
nephritis progression from ECM accumulation to fibrosis in humans, it may be suggested that 303 
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therapies that suppress factors in ECM production system and promote expression of factors 304 
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Figure legends 410 
Fig. 1. Periodic acid-Schiff (PAS) staining in tissues obtained on days 0 (A), 21 (B), 35 (C), 411 
and 63 (D) after HSV injection. Magnification, ×400. E) Percentage of mesangial area in 412 
PAS-stained sections at various time periods. *P < 0.001 versus day 0. 413 
Fig. 2. Immunostaining for type IV collagen in tissues obtained on days 0 (A), 21 (B), 35 (C), 414 
and 63 (D) after HSV injection. Magnification, ×400. E) Positive area of type IV collagen in 415 
glomerulus. *P < 0.001 versus day 0. 416 
Fig. 3. Immunostaining for HSP47 in tissues obtained on days 0 (A), 21 (B), 35 (C), and 63 417 
(D) after HSV injection. Magnification, ×400. E) Positive area of HSP47 in glomerulus. *P < 418 
0.001 versus day 0. 419 
Fig. 4. Immunostaining for TGF-β in tissues obtained on days 0 (A), 21 (B), 35 (C), and 63 420 
(D) after HSV injection. Magnification, ×400. E) Ration between no. TGF-β-positive cells 421 
and total cells in glomerulus. *P < 0.001 versus day 0. 422 
Fig. 5. Immunostaining for MMP-3 in tissues obtained on days 0 (A), 21 (B), 35 (C), and 63 423 
(D) after HSV injection. Magnification, ×400. E) Positive area of MMP-3 in glomerulus. *P 424 
< 0.001 versus day 0. 425 
Fig. 6. Immunostaining for Ets-1 in tissues obtained on days 0 (A), 21 (B), 35 (C), and 63 (D) 426 
after HSV injection. Magnification, ×400. E) Ration between no. Ets-1-positive cells and 427 
total cells in glomerulus. *P < 0.001 versus day 0. 428 






